NCT06084884 A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06079671 Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical) Status RECRUITING Phase PHASE3
NCT06077045 Uptake of the Childhood Live Attenuated Influenza Vaccine (LAIV) and Influenza-related Healthcare Resource Use in England During the 2012 to 2022 Flu Seasons; a Retrospective, Observational Study in the CPRD and HES Databases Status COMPLETED Phase N/A
NCT06075095 A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a Next-Generation Propellant in Participants 40 to 80 Years of Age With COPD Status COMPLETED Phase PHASE3
NCT06073574 CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06067828 A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD). Status COMPLETED Phase PHASE3
NCT06058988 Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer Status RECRUITING Phase PHASE2
NCT06057064 Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19 Status COMPLETED Phase PHASE2
NCT06056778 The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients With Reproductive Issues (PRISMA) Status COMPLETED Phase N/A
NCT06054035 SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes Status RECRUITING Phase PHASE4
NCT06053424 Positron Emission Tomography (PET) Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease Status COMPLETED Phase PHASE1
NCT06046534 Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs. Status COMPLETED Phase N/A
NCT06045975 Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06042049 A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab Status COMPLETED Phase PHASE3
NCT06040099 A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06040086 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06039683 A Multicountry, Multicentre, Non-interventional, Retrospective Study to Determine Real-world Treatment Patterns and Associated Outcomes After First Line Osimertinib in Patients With Advanced and Metastatic NSCLC EGFRm in the GCC Region Status COMPLETED Phase N/A